AURORA

From air pollution sources to mortality

Started
April 1, 2022
Status
In Progress
Share this project

Abstract

Atmospheric aerosols (or particulate matter, PM) are liquid or solid particles suspended in the air with diameters ranging from few nanometers to few tens of micrometers. Poor air quality associated with high levels of PM is a major public health problem, and is one of the five leading causes of premature deaths worldwide, alongside with high blood pressure, smoking, diabetes and obesity. Human exposure to PM caused ~8.9 million deaths, or ~10% of total global burden of mortality in 2015, more than car accidents, HIV and malaria combined. Without any action, these numbers are expected to double by 2050. PM health effects can be both acute and chronic, and have been associated with cardiovascular diseases, respiratory symptoms, different types of cancer, diabetes, sudden infant mortality, and neurodegenerative diseases (upon penetrating the blood-brain barrier). The magnitude of the association between PM exposure and the probability of death, is based on the total PM mass, while PM’s health effects is strongly driven by its chemical composition and size, and hence its origin. PM originates from natural (e.g. volcanoes, pollen) or anthropogenic (e.g. combustion) sources, and can be primary from direct emissions (e.g. metals from vehicular wear) or secondary, formed in the atmosphere through complex oxidation mechanisms of gaseous precursors (e.g. from trees, car/industrial exhaust, residential heating) (Fig. 1). Our ability to identify the major PM sources responsible for health outcomes is a two-fold challenge that requires (1) a fundamental understanding of PM emissions and formation processes and (2) the consideration of the high diversity and spatial heterogeneity of PM emissions, especially in urban settings where most of the population resides. AURORA unifies the expertise from distinct fields of science, including analytical & atmospheric chemistry, numerical modelling, epidemiology and medical science, to propose an innovative modelling framework, which integrates data-science, geo-statistics and process-based simulations to achieve a unique combination of source specificity, spatial and temporal coverage and resolution required for human exposure assessments. Model outputs will be combined with invaluable records of acute and chronic diseases developed and maintained over the course of 30 years to derive the pathogenicity of PM sources and their contribution to different health outcomes on a European scale.

People

Collaborators

SDSC Team:
Daniel Trejo Banos
Ekaterina Krymova
Guillaume Obozinski
Yun Cheng

PI | Partners:

PSI, Laboratory of Atmospheric Chemistry:

  • Dr. Imad el Haddad
  • Dr. Kaspar Rudolf Daellenbach
  • Dr. Petros Vasiliakos
  • Dr. Upadhyay Abhishek Kumar

More info

Swiss Tropical and Public Health Institute:

  • Prof. Nicole Probst-Hensch
  • Dr. Kees de Hoogh
  • Dr. Danielle Vienneau

More info

description

Motivation

The project aims to precisely characterise the distribution over time of air pollution in Europe between 2011 and 2019 and  assess the impact of air pollution on health outcomes in Switzerland.

Proposed Approach / Solution

SDSC along with the PSI partners develop methods for integrating PDE-based simulation of pollution transport with observations in over ~400 unique locations in Europe. We use statistics and machine learning to create a high-performing downscaling model that allows to recover the pollution profiles in different location, these profiles will be used as exposures in a survival analysis study in collaboration with TPH (Fig.2).

Figure 1. Levels and sources of PM10 and DTTvPM10 in Europe.
Figure 2. Diagram of the collaboration workflow, PSI provides expertise in pollution modeling, SDSC collaborates in developing statistical and ML models and the Swiss TPH guides the epidemiologic study with the exposures predicted by SDSC and PSI.

Impact

The correct estimation of the health impact of different pollutants is important to inform policy and drive further research in health outcome amelioration. Additionally, the machine learning advances in incorporating observations and simulations could provide useful results for related fields like climate and weather research.

Gallery

Annexe

Additional resources

Bibliography

  1. Chen, Y. et al. European aerosol phenomenology − 8: Harmonised source apportionment of organic aerosol using 22 Year-long ACSM/AMS datasets. Environ. Int.. 166,  107325 (2022)
  2. Zhang, X. et al. Ecological Study on Global Health Effects due to Source-Specific Ambient Fine Particulate Matter Exposure. Environ. Sci. Technol. 57, 1278–1291 (2023).
  3. Chen J. et al.  Long-term exposure to fine particle elemental components and natural and cause-specific mortality-a pooled analysis of eight European cohorts within the ELAPSE project. Environ Health Perspect. 129,4 :47009 (2021).

Publications

Related Pages

More projects

ML-L3DNDT

Completed
Robust and scalable Machine Learning algorithms for Laue 3-Dimensional Neutron Diffraction Tomography
Big Science Data

BioDetect

Completed
Deep Learning for Biodiversity Detection and Classification
Energy, Climate & Environment

IRMA

In Progress
Interpretable and Robust Machine Learning for Mobility Analysis
No items found.

FLBI

In Progress
Feature Learning for Bayesian Inference
No items found.

News

Latest news

Smartair | An active learning algorithm for real-time acquisition and regression of flow field data
May 1, 2024

Smartair | An active learning algorithm for real-time acquisition and regression of flow field data

Smartair | An active learning algorithm for real-time acquisition and regression of flow field data

We’ve developed a smart solution for wind tunnel testing that learns as it works, providing accurate results faster. It provides an accurate mean flow field and turbulence field reconstruction while shortening the sampling time.
The Promise of AI in Pharmaceutical Manufacturing
April 22, 2024

The Promise of AI in Pharmaceutical Manufacturing

The Promise of AI in Pharmaceutical Manufacturing

Innovation in pharmaceutical manufacturing raises key questions: How will AI change our operations? What does this mean for the skills of our workforce? How will it reshape our collaborative efforts? And crucially, how can we fully leverage these changes?
Efficient and scalable graph generation through iterative local expansion
March 20, 2024

Efficient and scalable graph generation through iterative local expansion

Efficient and scalable graph generation through iterative local expansion

Have you ever considered the complexity of generating large-scale, intricate graphs akin to those that represent the vast relational structures of our world? Our research introduces a pioneering approach to graph generation that tackles the scalability and complexity of creating such expansive, real-world graphs.

Contact us

Let’s talk Data Science

Do you need our services or expertise?
Contact us for your next Data Science project!